Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer	SWOG (Southwest Oncology Group)	Ongoing	CARVEDILOL	3	S1501	KFSH & RC-R
RELATED HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH SYMPTOMATIC SICKLE CELL DISEASE: A PROSPECTIVE STUDY	King Faisal Specialist Hospital and Research Centre	Ongoing	HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)	3	2191237	KFSH&RC-R
Re-EValuating the Inhibition of Stress Erosions and prophylaxis against gastrointestinal bleeding in the critically ill	KAIMRC	Ongoing	pantoprazole	3	CT19/009/R	King Abdulaziz Medical City NG (Riyadh)
Re-challenge therapy with chemotherapy and panitumumab in metastatic colorectal cancer patients treated with an anti-EGFR therapy in 1st line treatment: a phase II multicentre study.	King Abdullah Medical City, Holy Capital	Ongoing	PANITUMUMAB	2	19-504	KAMC
Randomized, two-way, two- period, single oral dose, open- label, crossover, bioequivalence study to compare Diclofenac Potassium powder for oral solution (50 mg diclofenac potassium) manufactured by Riyadh Pharma versus Catafast® powder for oral solution (50 mg diclofenac potassium) manufactured by Mipharm S.p.A., in healthy subjects under fasting condition.	Saudi Ajal	Ongoing	DICLOFENAC POTASSIUM	1, BE	42856	Saudi Ajal
Randomized, Open-Label, Phase II, Multicenter, Multi-Country Study to Evaluate Safety and Efficacy of Dasatinib 50 mg in First-Line Treatment of Early Chronic Phase Chronic Myeloid Leukemia	Hikma	Rejected	Dasatinib	2	LPI-JOR-LEB-KSA-TUN-	KFSH & RC - R
"Randomized, Open Label, Non-inferiority Study of Micafungin Versus Standard Care for the Prevention of Invasive Fungal Disease in High Risk Liver Transplant Recipients "	Astellas	Completed	Micafungin	3b	9463EC0001	NGHA-R
"Randomized, Embedded, Multifactorial Adaptive Platform trial for Community- Acquired Pneumonia (REMAP-CAP)"	KAIMRC	Ongoing	Ceftriaxone - Piperacillin Tazobactam - Azithromycin - Interferon β1-a - Hydrocortisone sodium suc... - Hydroxychloroquine - OSELTAMIVIR - Lopinavir-Ritonavir	3	CT20/001/R	NGHA-R
Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Solifenacin succinate film-coated tablets (10 mg solifenacin succinate) versus Vesicare® film-coated tablets (10 mg solifenacin succinate), in healthy subjects under fasting condition.	SPIMACO ADDWAEIH	Ongoing	solifenacin succinate	1, BE	42767	Saudi Ajal
Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition.	MEDIS Laboratories	Ongoing	Enoxa / Enoxaparin	3, BE	21-2017	Saudi Ajal